Tissue-specific properties of type 1 dendritic cells in lung cancer: implications for immunotherapy
Checkpoint inhibitors have led to remarkable benefits in non-small cell lung cancer (NSCLC), yet response rates remain below expectations. High-dimensional analysis and mechanistic experiments in clinical samples and relevant NSCLC models uncovered th…